Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins.
Gazi IF, Boumpas DT, Mikhailidis DP, Ganotakis ES. Gazi IF, et al. Among authors: ganotakis es. Clin Exp Rheumatol. 2007 Jan-Feb;25(1):102-11. Clin Exp Rheumatol. 2007. PMID: 17418000 Review.
The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin.
Krijgsman B, Papadakis JA, Ganotakis ES, Mikhailidis DP, Hamilton G. Krijgsman B, et al. Among authors: ganotakis es. Int Angiol. 2002 Mar;21(1):44-52. Int Angiol. 2002. PMID: 11941273
Beneficial effect of moderate alcohol consumption on vascular disease: myth or reality?
Papadakis JA, Ganotakis ES, Mikhailidis DP. Papadakis JA, et al. Among authors: ganotakis es. J R Soc Promot Health. 2000 Mar;120(1):11-5. doi: 10.1177/146642400012000111. J R Soc Promot Health. 2000. PMID: 10918777 Review.
Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
Papadakis JA, Ganotakis ES, Jagroop IA, Winder AF, Mikhailidis DP. Papadakis JA, et al. Among authors: ganotakis es. Int J Cardiol. 1999 Jun 1;69(3):237-44. doi: 10.1016/s0167-5273(99)00013-3. Int J Cardiol. 1999. PMID: 10402106
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.
Mikhailidis DP, Ganotakis ES, Spyropoulos KA, Jagroop IA, Byrne DJ, Winder AF. Mikhailidis DP, et al. Among authors: ganotakis es. Int Angiol. 1998 Dec;17(4):225-33. Int Angiol. 1998. PMID: 10204653
Fibrinogen as a cardiovascular risk factor.
Breimer LH, Ganotakis ES, Mikhailidis DP. Breimer LH, et al. Among authors: ganotakis es. Rev Port Cardiol. 1997 Mar;16(3):245-50. Rev Port Cardiol. 1997. PMID: 9141902 Review. No abstract available.
Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
Vrentzos GE, Papadakis JA, Ganotakis ES, Paraskevas KI, Gazi IF, Tzanakis N, Nair DR, Mikhailidis DP. Vrentzos GE, et al. Among authors: ganotakis es. Int J Clin Pract. 2007 Oct;61(10):1643-53. doi: 10.1111/j.1742-1241.2007.01527.x. Int J Clin Pract. 2007. PMID: 17877651
Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia.
Papadakis JA, Ganotakis ES, Jagroop IA, Mikhailidis DP, Winder AF. Papadakis JA, et al. Among authors: ganotakis es. Am J Hypertens. 1999 Jul;12(7):673-81. doi: 10.1016/s0895-7061(99)00049-7. Am J Hypertens. 1999. PMID: 10411364
Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
Lioudaki E, Stylianou KG, Petrakis I, Kokologiannakis G, Passam A, Mikhailidis DP, Daphnis EK, Ganotakis ES. Lioudaki E, et al. Among authors: ganotakis es. Nephron. 2015;131(1):34-42. doi: 10.1159/000438493. Epub 2015 Sep 5. Nephron. 2015. PMID: 26340089
Smoking, diabetes and hyperlipidaemia.
Mikhailidis DP, Papadakis JA, Ganotakis ES. Mikhailidis DP, et al. Among authors: ganotakis es. J R Soc Health. 1998 Apr;118(2):91-3. doi: 10.1177/146642409811800209. J R Soc Health. 1998. PMID: 10076642 Review.
70 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback